Home » Topics » Regulatory » Patents

Patents
RSS

Daiichi discloses CCK-B/gastrin receptor antagonists

Nov. 8, 1996

Fujisawa claims fibrinogen antagonists

Nov. 8, 1996

Canadian researchers claim hirudin derivative

Nov. 8, 1996

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Antianginal and antiulcer agents from Sankyo

Nov. 8, 1996

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

Warner-Lambert claims NK3 antagonists with broad therapeutic applications

Nov. 8, 1996

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.